Category Archives: Stem Cell Doctors

Denver Stem Cell | Area’s Leading Stem Cell Doctors

Colorado Pain Care LLC 2696 S. Colorado Blvd Suite 110 Denver, CO 80222 Office Hours: Mon - Fri 8AM-5PM

2017 DenverStemCell.com. All Rights Reserved.

Dr. Jason Krutsch and the Denver Stem Cell team are thrilled to offer you the best in Regenerative Therapies for your painful orthopedic condition. Your care is provided by Medical Doctor Anesthesiologists, a 5280 Magazine Top doctor and the finest procedural team in Denvers Front Range!

It all starts with an accurate diagnosis. In your FREE 1 hour initial consultation, Dr. Krutsch will utilize patient history, focused physical exam and advanced imaging to determine what type of candidate you are for Regenerative Medicine and which therapy is best for you.

You will learn about the incredible benefits of Stem Cell and Platelet Rich Plasma and how it can help reverse painful conditions like osteoarthritis and muscle/tendon tears. A customized rehab program is part of every patients treatment. With the Denver Stem Cell team you could be on your way to rebuilding cartilage, rejuvenating your body and reclaiming your life!

CALL NOW for aFREE CONSULT!

In Pain? There is Hope for Relief & Higher Quality of Life.

Knee osteoarthritis and meniscal tears

Shoulder rotator cuff tears, impingement and arthritis

Ankle and Foot Arthritis, chronic sprains

Neck Pain, Low Back & Hip Pain

Denver Stem Cell is all about using your own cells to repair damaged tissue from arthritis or injury. The most researched and clinically proven areas to treat with stem cells and PRP are joints, muscles and tendons. Treating conditions like diabetes and autoimmune diseases with stem cell therapy is still considered experimental. Here is a list of the most common areas treated by Denver Stem cell:

Schedule your FREE CONSULT with Dr. Krutsch!

Learn more in this patient success story.

Colorado Pain Practice, LLC (Colorado Pain Care) cannot guarantee any results of stem cell or regenerative therapy. Colorado Pain Care is not offering stem cell therapy or any other regenerative therapies as a cure for any condition, disease, or injury. No statements or implied treatments made in these materials or otherwise discussed with respect to stem cell or regenerative therapy have been approved or disapproved by the FDA. Colorado Pain Care does not claim that any applications or potential applications using stem cells or regenerative therapy are approved by the FDA or are even effective. Colorado Pain Care does not claim that these treatments work by an listed or unlisted condition, intended or implied. Colorado Pain Care strongly encourages all potential patients to talk with their doctor and do their own research based on the options presented in order to make a fully informed decision before choosing to move forward with considering stem cell or regenerative therapies. All statements provided in these specific materials are for educational and informational purposes only and do not constitute medical advice.

More here:
Denver Stem Cell | Area's Leading Stem Cell Doctors

Stem Cell Research Facts | Charlotte Lozier Institute Project

Learn the answers to questions like ..."Who is benefitting from stem cell research and therapies today?" and "What types of stem cells are working?" In addition, basic questions such as "What is a stem cell?""Why do we need stem cell research?" are answered.

The video patient profiles featured on this site emphasize ADULT stem cell advances with the goal of informing and the hope of inspiring you to take action. These stories represent a small sampling of people and the many diseases and conditions now being treated by adult stem cells naturally found in the human body. Stem Cell Research Facts illustrates how current adult treatments and therapies directly impact the lives of patients and their families today - as opposed to debating the merits of other types of stem cell research.

We invite you to discover, learn and share the incredible possibilities of stem cell research. We welcome your feedback and encourage you to return for the latest developments in the world of stem cell research. Thank you!

More:
Stem Cell Research Facts | Charlotte Lozier Institute Project

Meet Dr. Garg, M.D., Experienced Stem Cell Doctor

Meet the Leading Expert in Regenerative Medicine (Autologous Adult Stem Cell Treatments) For Non-Surgical ALTERNATIVES to Your Orthopedic Conditions, Such as Problems of the Spine, Hip, Knee, Shoulder, & Other Joints from Arthritis, Sports Injuries and other common medical conditions.

Hardesh Kumar Garg, M.D., is pioneering effective and safe, non-surgical alternatives to orthopedic and sports surgery.

He is a leading physician in the United States specializing in emerging and exciting field of Adult Stem Cell and PRP treatments, Anti-Aging Medicine and Sports Medicine.

Dr. Garg is one of the few physicians in the United States who are trained in this specialized field of Regenerative Medicine. He uses your own (Autologous) stem cells from Bone Marrow, and Fat; along with Platelet-Rich Plasma (PRP) and anti-aging hormone replacement protocols. He has also designed specialized supplements to boost immune system and decrease chronic bad inflammation in your body, thus increasing the success of his stem cell/regenerative medicine procedures for his patients.

He has helped many patients from around the country by treating their pain and injuries with his unique clinical protocols combining Bone Marrow Stem Cells, Adipose (Fat) Derived Stem Cells and Platelet-Rich Plasma (PRP), while boosting their immune and hormone systems with hormone balancing protocols and nutritional/herbal supplementations.

People suffering from back and neck pain, sports and auto injuries, arthritis or other serious pain often fear visiting doctors because they dont want to hear the word surgery. The fear is even greater among senior citizens as the healing process may take longer, complications can be more dramatic and results more difficult to perceive.

Dr. Garg provides high quality, cutting-edge, proven, safe and cost-effective alternatives to dangerous and costly orthopedic joint, tendon and spine surgeries.

He has served as clinical assistant professor at the Department of Internal Medicine at the University of Florida School of Medicine and has also worked as a courtesy clinical assistant professor at the University of South Florida School of Medicine.

Dr. Garg has experience working with professional and amateur athletes from different sports to increase their performance with this unique and individualized health and wellness program. He has worked with professional athelets like former number one PGA Tour Golfer, several NFL players, many Tennis athletes and athletes from various other sports.

Affectionately known as Dr. G to his patients, an internal medicine specialist, received his medical degree from the University of Delhi, India and completed post-graduate training in internal medicine from West Virginia University Health Sciences Center (Morgantown, WV) in 1993.

As a clinician, researcher, teacher, scientist and writer, Dr. G has been practicing medicine for more than 20 years.

He worked as sub-investigator in a National Institute of Health-funded research study seeking genetic information on obesity.

He has served as a member of the Medical Advisory Board of H Magazine, a publication of The Florida Times-Union, Jacksonville's daily newspaper.

He also served as the national medical advisor for a national chain of weight loss centers.

He was a speaker for major International Pharmaceutical companies like Pfizer and Bristol- Myers-Squibb.

Dr. G is a member of Duval County Medical Society, American Academy of Pain Medicine, American Academy of Anti-Aging Medicine and American Society for Laser Medicine and Surgery.

Publications:

Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations - John J. Lima(a), Hua Feng(b), Laurie Duckworth(a), Jianwei Wang(a), James E. Sylvester(a), Niranjan Kissoon(c),Hardesh Garg(d).

Metabolism Clinical and Experimental 56 (2007) 757 765, Received 11 September 2006; accepted 2 January 2007

Professional Presentations:

Clinical Investigator:

Principal Clinical Investigator, Clinical Research:

Read the original:
Meet Dr. Garg, M.D., Experienced Stem Cell Doctor

A Napa family struggles to give their child a normal life – Napa Valley Register

Every mom anticipates her childs first day at kindergarten.

For Jessica Pequeno, that kind of milestone is something this mom is only now ready to imagine.

The last time the Napa Valley Register wrote about the Pequeno family, it was October 2015. Their then 22month-old toddler Xavier was about to begin the fight of his life against an immune deficiency disorder so rare it had no name.

Today, there is good news about Xavier and his family.

The now 4-year-old completed a grueling, yet successful stem cell transplant, just started his second year of preschool and is making progress with his health, said his mother. Come this time next year, shell be enrolling him in kindergarten.

Every day is different. We still deal with so many unknowns, she said. But, Hes doing so much better than anybody would have ever expected.

Just getting to this point was a long road.

Two years ago, the Pequenos told their story in hopes of finding a bone marrow transplant match for their son. Doctors originally told them there was no match within the family. Fortunately, after a second set of tests, the Pequenos middle son, Higinio Pequeno IV, was identified as a partial match.

That news was awesome, said Jessica Pequeno.

The family prepared for the transplant to take place in June 2015, but a stubborn infection put those plans on hold. By December, his health care team at the University of California at San Francisco wouldnt even give us odds as his percentage of survival because they didnt know, she said.

They finally had a name for his disease IKBa gain of function mutation with ectodermal dysplasia but there were too many unknowns.

Pequeno said she realized the stem cell transplant was a kind of a now-or-never situation.

We just kept saying, We just have to keep doing this. Giving up wasnt an option.

On Dec. 1, 2015, Xavier was admitted to the hospital for the transplant. The process began with eight days of chemotherapy followed by the stem cell transplant.

Putting a line in his femoral artery, blood was collected from Higinio, then 10. Then a machine separated the stem cells from the blood. Higinios stem cells were then given to Xavier. The stem cells were put into a vein, much like a blood transfusion. The stem cells are then meant to travel to the bone marrow, engraft, and hopefully begin making new, normal blood cells.

On the day of the transplant, the whole Pequeno family, including her husband Higinio, son Higinio and daughter Maya and Jessica Pequenos mom were there. Seeing those potentially life-saving cells go into her son was very emotional, said Jessica Pequeno.

We all cried, she said. It was really scary, but you cant stop. You have to keep going.

During the procedure, Xavier was awake, she said. But the side-effects of the chemotherapy were starting to set in. His hair was falling out, and he had stopped eating and drinking because his mouth sores were so bad and painful, she said. He was on morphine for the pain.

The waiting began. Would the stem cell transplant be a success?

The family was told that Xavier would likely spend many months in the hospital. We planned to be separated as a family for at least six months, said Pequeno. We just expected it to be really hard.

She spent her nights in the room with her son, sleeping on a blow-up twin mattress. The rest of her family went back to Napa. Because Jessica was unable to work and her husband couldnt work because he needed to have knee surgery, the family had moved in with Jessicas mother.

Meanwhile, doctors continued to check Xaviers blood to see if his body was responding to the stem cell transplant.

Every day Id ask, Where are we at? his mother said.

And then, one day in early January, the doctors came to see Xavier, and they said, We have good news.

The transplant was starting to work and the new cells were starting to grow, she said.

I cried, said Pequeno. It happened so much faster than what they had expected.

By the end of January, Xavier was well enough to go home to Napa.

It was scary to come home and super exciting, she said.

Back at home, a new routine was created. Xavier was still taking 25 different medications, some multiple times per day. He had a gastrostomy or G tube for feeding the nutritional liquid he eats and a central line a thin, flexible tube used to give medicines, fluids, nutrients, or blood products over a long period of time.

Honestly I dont remember a lot of it. It becomes a big blur, said Pequeno.

The family continued to visit UCSF at least once a week for blood counts and other checks. There were more ups and downs. Infections and illnesses caused him to be hospitalized for days at a time in February, May and June. His central line got infected. He got shingles.

His immune system was still really weak, said Pequeno.

But he kept bouncing back.

Just two weeks ago, doctors finally removed his central line.

It was a huge step, she said.

Challenges remain. Before the stem cell transplant, Xavier had about 5 to 10 percent of a normal immune system. Now he has about 60 to 70 percent, doctors said.

Were starting to learn hes really prone to sinus and respiratory infections, and viruses, said Pequeno. His body just doesnt fight like everyone elses.

Other habits are harder to change.

Before Xavier went to preschool, Pequeno and her family were able to carefully control his exposure to germs.

When he was able to go to preschool, I wasnt in control of those environments anymore. Its really hard. It gets easier, but it takes a while to learn how to kind of let go, she said.

Today, Xavier takes only six medications a day and can receive infusions of antibodies at home. Visits to UCSF have been cut back to once every four to five weeks.

Developmentally, Xavier is doing well, she said.

He has some hearing loss, which we continue to monitor. Its hard to say if its a side effect of chemo or other drugs. Right now it doesnt affect his speech. He also has skin, hair and teeth health issues to manage.

Xavier doesnt complain at lot, said Pequeno.

Hes always handled everything so well. When he suffered, He would get quiet. Even now when hes not feeling good, instead of crying like many small children would, Xavier is quiet.

Financially, its hard because Im still not able to work, she said.

Xaviers medical care is provided by Partnership HealthPlan/Medi-Cal and California Childrens Services. Her husband went back to work. Pequeno is taking classes at Napa Valley College while her son is in preschool.

I want to be a nurse but I want to go into pediatrics I want to teach parents how to advocate for their kids.

One of the most significant changes for Pequeno was becoming more confident in working with health care providers regarding her sons care.

Nobody could hand me a book when this started (that said) these are the things you need to know and questions to ask. No one told me I was the captain of his team. Her confidence grew. You have to get comfortable in that role.

The past several years have left a lasting imprint on the whole family, she said. Signs of post-traumatic stress have been seen in all family members. Learning coping skills and how to manage stress is important.

Especially for their son Higinio, said his mother. Its not easy for young boy to come to terms with what his brother went through and his own unique contribution.

I dont think any 10-year-old is capable of understanding the weight that carries, she said.

The struggles havent ended, said Pequeno.

Weve just learned to manage them and adjust and deal with the financial part. We juggle. You learn how to change your priorities.

Its easy to say her son looks healthy, said Pequeno, but thats also frustrating because it takes so much work to get him to continue to look like that.

It definitely takes a toll and lot of work and sacrifice to keep him where hes at, she said.

And Xaviers condition isnt going away, she noted. This is something we will manage for the rest of his life one way or the other.

People say, Oh youre so strong. But I think that as a mom, you just do it, said Pequeno. You pull the strength from somewhere. Because you dont give up on your kids.

Read the original post:
A Napa family struggles to give their child a normal life - Napa Valley Register

Ryan Custer, Elder grad injured at Oxford party, thanks community for their support – WCPO

CINCINNATI -- Ryan Custer tearfully thanked the community for their support at his prayer service Sunday.

I cant thank you guys enough, he said in front of a standing ovation at Elder High Schools Fieldhouse.

Custer, an Elder grad and Wright State freshman, suffered a traumatic spinal injury at a large party in April after he tried to jump into a shallow, makeshift pool.

Family and friends welcomed Custer home on Wednesday. He had been been recovering and undergoing therapy at University of Cincinnati Medical Center. He also traveled to Chicago to be considered for a stem cell study at Rush University.

Doctors injected 20 million stem cells into Custers neck, and HBO has been following his progress.

Ryans brother, Nick Custer, thanked the West Side community for being so uplifting to his family.

It means the world to us. It just shows you what a special kid Ryan is as a 19-year-old kid going through this, its just overwhelming support, he said.

Nick said Ryan will continue rehabilitation in Cincinnati, and he said Ryan is looking forward to the start of Wright States season.

Ryan wants to get back to the team as soon as possible, and they all want him to come back and help however he can. He misses them, definitely, Nick said.

View original post here:
Ryan Custer, Elder grad injured at Oxford party, thanks community for their support - WCPO

Stem Cells and "Mishandling" Smallpox – Liberty Nation – Liberty Nation (registration) (blog)

GABRIELLA FIORINO

We trust our doctors with our lives. However, what is the reaction when some medical professionals allow unsanitary measures and diseases to break out into the population? Four institutions in the U.S. came under fire recently by the FDA for improperly handling microbiological organisms and exposing the public to smallpox after conducting unapproved techniques, endangering hundreds of lives.

The FDA identified four medical centers in California and Florida as utilizing unapproved stem cell therapies for those with cancer and other serious illnesses. One of the institutes, California Stem Cell Treatment Centers, applied a method developed by StemImmune Inc., which consisted of injecting clients with a mixture of the smallpox vaccine and stem cells. Dr. Mark Berman, co-founder of the California center, described their methods as cutting edge therapy for stage-4 cancer patients, as reported by the Los Angeles Times.

The consequences of such methods are worrisome; as the FDA claims exposure to the smallpox vaccine significantly increases the risk of life-threatening complications, including heart inflammation. Perhaps even more troubling is the fact that individuals in contact with those receiving the vaccine may develop similar symptoms, possibly infecting hundreds of others. The FDA is currently investigating how StemImmune Inc. received shipments of the vaccine, as the product is unavailable on the market.

The Stem Cell Clinic of Sunrise, Florida is another facility under investigation by the FDA for taking improper sanitary measures to prevent contamination during their therapies. According to the agency, the clinic refused to permit entry of an FDA inspector without an appointment, which is a violation of federal law. This refusal would not be the first time the Florida institution came under fire. According to the New England Journal of Medicine, three clients suffering from macular degeneration sustained blindness following treatment at the facility.

A variety of sources derive stem cells, including bone marrow, blood, umbilical cords, and controversially, human embryos. These products aid in the development and restoration of healthy human tissue, and help battle cancer, heart disease, and Parkinsons disease, as noted by the University of Utah. These products are also employed for spinal cord injuries, indicating critical applications, as the central nervous system does not naturally permit neuro-regeneration following damage. Excitingly, organs growth for those requiring life-saving transplants is another possible advancement.

These innovations are not without consequences, however. According to the Mayo Clinic, some may develop graft-versus-host disease, a condition in which a donors stem cells attack the patients tissues and organs, possibly leading to death. Risks of brain tumor development are also an increased possibility for those receiving injections in the spinal cord, as abnormal tissue growth may result.

As the FDA investigates unsound practices by the four institutes endangering the lives of hundreds, Americans should not be misled regarding stem cell therapies. Through proper sanitary measures, their uses are a huge medical development, comprising a myriad of medical advantages. Liberty Nation will keep readers up to date regarding the actions of the FDA against the four clinics.

Gabi is a Biomedical Sciences major and manages a Cognitive Neuroscience Research Lab at the University of Central Florida. A Libertarian, Gabi says shes surrounded on by whiny, wannabe anti-capitalists, posting about their victimhood on Facebook.Although leftists often confuse her with privileged white girls, Gabi is Puerto Rican and Italian.Make sense of that, liberals!

Stem Cells and Mishandling Smallpox - September 3, 2017

The Politics of College Millennials Exclusive Interviews Part I - August 28, 2017

Research: Lying Children May Have A Knack For Strategic Thinking - August 24, 2017

Read more:
Stem Cells and "Mishandling" Smallpox - Liberty Nation - Liberty Nation (registration) (blog)

For Lowell native, stem cell match becomes a match as friends – Lowell Sun

From left to right: Richard Stone, a doctor at Dana-Farber Cancer Institute in Boston, poses with Peter Karalekas (center), 76, and Matthew Churitch, 22. Churitch donated stem cells to Karalekas two years ago, and he visited Dana-Farber with Karalekas earlier this summer. (Courtesy photo)

BOSTON -- After winding his way through Massachusetts, Connecticut, New Hampshire and Maine for 76 years, Peter Karalekas has a proclamation: He's a Southerner now.

He still lives in Kittery, Maine, just about an hour from the Lowell middle school where he taught for 21 years.

He has no plans to move.

Rather, Karalekas considers himself a Southerner because of his stem cells.

He never exactly felt all that sick.

Karalekas worked tirelessly for decades, first as a teacher and coach at the James S. Daley Middle School in Lowell and then as the owner of a half-dozen T-Bones restaurants across New Hampshire.

Even despite the 12-hour days, seven days a week, in the grind of the restaurant industry, Karalekas felt healthy and rarely fell ill.

Peter Karalekas, left, a 76-year-old former Lowellian, smiles during his first meeting with Matthew Churitch, 22, of Nashville, Tennessee, who helped save Karalekas life by donating stem cells. (Courtesy photo)

The two, who do not have children, moved to Kittery 17 years ago.

Everything started to change in 2014.

Karalekas recalls being "short-winded," but he had very few other symptoms when he was diagnosed with myelodysplastic syndrome, a rare type of cancer in which the bone marrow is damaged and cannot produce enough blood cells.

The prognosis was not good.

"They said the only thing that would save me was a stem cell transplant," Karalekas said. "Otherwise, I had a couple of months to live, because my cells were all dropping drastically.

He went onto a registry, hoping for a donor to pop up, but doctors told him it could take from six months to two years to find the right match. Even with a transplant, Karalekas said, his chances of success were "30 to 40 percent."

The call came four weeks later.

Matthew Churitch got his call quickly, too.

He joined the National Marrow Donor Program's Be the Match Registry in 2014, the summer between his freshman and sophomore years at Clemson University. His mother had been on the registry to donate for years. Churitch's decision was simple: When a friend was diagnosed with leukemia, he knew he should sign up, too.

He did the requisite cheek swab, unsure if he would ever even be contacted to donate. By the time he had finished the following semester, he got the call.

A match was found.

Churitch went through several more levels of testing and preparation to donate stem cells to a stranger. He went to Clemson's student health center to have blood drawn.

He returned to his native Nashville, Tennessee, going to a medical center 10 days in a row to receive shots in his stomach that would stimulate his bone marrow and prepare his cells for transplant.

He sat for eight hours, a needle in each arm as his stem cells were filtered out so they could be transferred to Boston.

"Getting the shots isn't fun," he said. "You're pretty sore afterward for a few weeks. But knowing that the person on the other end is in hundreds and hundreds times more pain than any donor would ever go through -- that kind of pushed me through."

Karalekas and Churitch first connected via an anonymous letter, per the transplant registry's rules, updating Churitch on Karalekas's lengthy, isolated recovery. They were able to speak directly after a year.

Churitch dialed Karalekas' number on a lengthy walk to class, took a deep breath and hit the call button. Moments later, both men were crying and laughing.

"That was really awesome, just being able to hear his voice and recognize that there's somebody else on the other end of this," Churitch said. "A lot of people don't get the chance to connect with their recipients or their donors."

Karalekas wanted more. He told his wife early on that he wanted to meet his "angel from heaven," so when Churitch graduated Clemson earlier this year, Karalekas paid to bring the 22-year-old and his mother to New England.

In late June, Karalekas and his wife pulled into a pickup lane at Logan International Airport in Boston.

"I got out of the car, I charged over, and I gave them both a huge hug," Karalekas said.

Karalekas showed Churitch and his mother around for five days.They went on a private tour of Fenway Park; they wandered the historic streets of Portsmouth, New Hampshire; they visited Dana-Farber together to meet the team that treated Karalekas.

Both families quickly bonded. Karalekas recalls his brother George asking Churitch about his portable phone charger, expressing curiosity about how convenient it was. A few weeks later, a brand-new portable charger arrived at George's door, a gift from Churitch.

In January, Karalekas and his wife will vacation in Arizona and will cheer on Churitch's mother -- without Churitch even present -- in the Phoenix Marathon.

Donor and recipient talk every week.

"It's like we're a very, very close-knit family now," Karalekas said. "He's the son we never had."

Churitch is now in his first year at the University of South Carolina School of Medicine Greenville with hopes of becoming a physician. He hopes to use Karalekas's experience as inspiration for any patients facing future hardship, and he hopes that others, especially young people, will see their success and join the registry.

"You never know where that will take you," he said. "You can gain a friend for life, impact somebody and their family in need."

Karalekas said he feels he has a new life: His chances of beating the disease are now 97 percent, he says, up from the 30 percent or 40 percent when he started treatment. Thanks to the transplant from a handsome, athletic college student in Tennessee.

"I said, 'I'm a Southerner now,'" Karalekas said. "My stem cells are 99 percent this gentleman. I'm 99 percent him."

Follow Chris on Twitter @ChrisLisinski.

The rest is here:
For Lowell native, stem cell match becomes a match as friends - Lowell Sun

Brain cell replacement for Parkinson’s boosted by monkey study – The San Diego Union-Tribune

A brain cell replacement therapy reduced Parkinsons disease symptoms in monkeys, Japanese researchers report in a study released Wednesday. The positive result boosts prospects to test the therapy in people.

The goal is to implant neurons derived from stem cells into the brains of Parkinsons patients, a project pursued by scientists in San Diego, New York, Britain and Sweden as well as in Japan. If all goes well, the neurons will function as replacements for those destroyed in the disease.

In addition, human testing of a related brain cell therapy from Carlsbads International Stem Cell Corp. is already under way in Australia.

While treatments exist for the movement disorders caused by Parkinsons, none of them actually halt progression. Replacing the brain cells destroyed in Parkinsons holds the promise of actually reversing the disease.

Moreover, success with Parkinsons could pave the way to treating many other neurodegenerative diseases, such as ALS (Lou Gehrigs disease) and perhaps Alzheimers, along with brain and spinal cord injuries. These afflictions cost hundreds of billions annually, and most importantly, produce immense suffering in patients and caregivers.

Years of extensive research are required before any such therapy can be tried in people. Testing in monkeys or other primates is often regarded as the last step before human treatment can be contemplated.

The study was published in the journal Nature. Its senior author was Jun Takahashi, a prominent stem cell researcher at Kyoto University in Kyoto, Japan. Go online to j.mp/parkips for the study.

There is precedent to suggest the therapy might work. Beginning decades ago, brain cells taken from human fetuses have been implanted into the brains of Parkinsons patients, with mixed results. Some patients experienced improved movement control. But others gained nothing, or experienced uncontrolled movements.

Scientists in the field say using stem cells should provide improved results. Stem cells can be made in greater quantity than the limited number of fetal brain cells available. In addition, the stem cells and neurons made from them can be analyzed for quality before implantation.

The study was praised by regenerative medicine researcher Tilo Kunath at the University of Edinburgh, in comments provided by the UK Science Media Centre.

This is extremely promising research demonstrating that a safe and highly effective cell therapy for Parkinsons can be produced in the lab, Kunath said.

Such a therapy has the potential to reverse the symptoms of Parkinsons in patients by restoring their dopamine-producing neurons. The next stage will be to test these therapies in a first-in-human clinical trial.

In the study, researchers produced neurons that secrete dopamine, a neurotransmitter deficient in Parkinsons disease. These neurons were made from human stem cells derived from both healthy people and those with Parkinsons.

The researchers then implanted the human neurons into 10 monkeys whose own dopamine-making neurons had been destroyed. The monkeys were given immunosuppressive drugs to prevent rejection of the human cells.

The human neurons integrated into the brains of the monkeys and functioned as dopamine-making neurons. The monkeys improved in movement ability, save for one monkey that became ill and was euthanized. Both cells from healthy and Parkinsons patients were effective.

A companion study in Nature Communications demonstrated a method of immune-matching the cells to reduce the immune response. Takahashi was also senior author of that study. Go online to j.mp/ipsimmune for the study.

Both studies used artificial embryonic stem cells, called induced pluripotent stem cells (IPS). These act-alike cells are not derived from embryos, but are genetically reprogrammed from adult cells, usually skin cells.

The IPS cells appear to act virtually identically to embryonic stem cells, but dont raise the ethical objections many have to using embryonic stem cells. These cells were invented in 2006 by a team led by Shinya Yamanaka, a co-author of the Nature Communications study.

Moreover, the cells can be made from the patients themselves, which is not expected to cause an immune reaction. This is the approach taken by the San Diego team, including scientists at The Scripps Research Institute.

Carlsbads International Stem Cell Corp. uses a different approach. It starts with unfertilized, or parthenogenetic, human egg cells. These are grown into immature neurons that are implanted. The cells are expected to grow not only into dopamine-making neurons, but other kind of brain cells that preserve the remaining neurons.

The Australian clinical trial has gathered evidence of safety, and continued testing is under way determine efficacy.

The Nature study dovetails with research by the San Diego group, Summit for Stem Cell, (www.summitforstemcell.org), including scientists at The Scripps Research Institute and doctors at Scripps Health.

The group proposes to treat Parkinsons patients with neurons grown from their own IPS cells. The scientists have received funding from the California Institute for Regenerative Medicine, the states stem cell agency.

The studies support the personalized approach that we are taking for a neuron replacement therapy for Parkinson's disease patients, said Jeanne Loring and Andres Bratt-Leal, stem cell scientists at The Scripps Research Institute.

Two points from the studies should be highlighted, Loring and Bratt-Leal said by email.

Parkinson's disease is a late-onset disorder, they said. That means that there was nothing wrong with the neurons that people with Parkinson's were born with. Few PD patients have a family history of the disease, which suggests that genetic mutations did not cause their disease.

So for the great majority of patients, transplantation of their own neurons is a promising approach to relieving symptoms, without having to take expensive and risky immunosuppressive drugs, they said.

The Summit for Stem Cell scientists are members of an international partnership of laboratories developing neuron replacement therapies for Parkinsons, called GForce PD.

Takahashi belongs to the partnership, as do scientists in the UK, Sweden and New York. These use both embryonic and IPS stem cells. The Summit for Stem Cell effort is the only one using patient-matched IPS cells, Loring and Bratt-Leal said.

Brain cells reprogrammed to make dopamine, with goal of Parkinsons therapy

Parkinson's stem cell therapy shows signs of safety

Parkinson's therapy funded by California's stem cell agency

Dopamine-making neurons can be chemically controlled in animal model of Parkinson's

Stem cell clinical trial for Parkinson's begins

Summit for Stem Cell

bradley.fikes@sduniontribune.com

(619) 293-1020

Link:
Brain cell replacement for Parkinson's boosted by monkey study - The San Diego Union-Tribune

Collaboration Key to 3D Bioprinting Stem Cell Research Success at BioFab3D@ACMD in Australia – 3DPrint.com

Medical researchers and scientists have created all kinds of medical marvels, from brain tissue and cartilage to a heart and a pancreas, by 3D printing stem cells. In Australia, Swinburne University of Technology PhD candidateLilith Caballero Aguilar is currently collaborating on a project with surgeons and researchers at BioFab3D@ACMD, the countrys first bioengineering facility based in a hospital, about how stem cells are fed once theyre inside the body. She is working to develop methods to control the rate of release for growth factors, which stem cells need for development once theyve been implanted, and the research could help doctors use biological 3D printing techniques to regenerate damaged or missing tissue.

Caballero Aguilar says that working alongside surgeons and other university researchers at the facility has had a major impact on her work.

We complement each other. If I have doubt, we can discuss it and reshape the project as we go, which helps to reach a better outcome.At the end of the day, everyone is doing a bit of work in a big project. It feels very rewarding,Caballero Aguilar said.

The facility was established through a partnership between Swinburne, St Vincents Hospital Melbourne, the ARC Centre of Excellence for Electromaterials Science, the University of Melbourne,RMIT University, and the University of Wollongong Australia. Biology experts, surgeons, researchers, and biomedical engineers work at the facility to pioneer innovations, like nerves, re-engineered limbs, and tissues.

Cellink Inkredible Bioprinters [Image: Swinburne]

Caballero Aguilars stem cell work is part of two of the facilitys major research projects, one which focuses on repairing damaged muscle fibers and another regarding damaged cartilage regeneration; both are using advanced technologies, like bioprinting, to implant materials into the body, including the handheld 3D Biopen that allows surgeons to draw biomaterials into a patient directly and has been successfully tested, using knee cartilage, on six sheep.

BioPen

She is working to manipulate polymer materials into release mechanisms for stem cell growth factors, which would form part of the 3D bioink drawn into the body. Controlling the delivery of growth factors is very important stem cells take at least six weeks to grow into tissue, so the growth factors need to be slowly released over the entire time period.Caballero Aguilar shakes an oil and water solution at an intense rate, which is called the emulsion method, to create microspheres, which are crosslinked to form a substance thats able to hold the growth factors.

Swinburne Professor of Biomedical Electromaterials Science Simon Moulton, who is Caballero Aguilars supervisor, said that the success of her stem cell research project was helped along by the opportunity to collaborate directly with orthopaedic surgeons and muscle specialists at St Vincents Hospital.

Swinburne PhD candidate Lilith Caballero Aguilar and Professor Simon Moulton in a lab at BioFab3D@ACMD. [Image: Swinburne]

Professor Moulton said, Without this space, Liliths project would be a much smaller project without the translation benefit.It still would be great research done at a very high level, she would have publications and be able to graduate, but working in this collaborative environment, she can achieve all of that, while also having her research go into a clinical outcome that actually has benefit to patients.

Continue reading here:
Collaboration Key to 3D Bioprinting Stem Cell Research Success at BioFab3D@ACMD in Australia - 3DPrint.com

FDA cracks down on stem-cell clinics selling unapproved treatments – 89.3 KPCC

The Food and Drug Administration is cracking down on "unscrupulous" clinics selling unproven and potentially dangerous treatments involving stem cells.

Hundreds of clinics around the country have started selling stem cell therapies that supposedly use stem cells but have not been approved as safe and effective by the FDA, according to the agency.

"There are a small number of unscrupulous actors who have seized on the clinical promise of regenerative medicine, while exploiting the uncertainty, in order to make deceptive, and sometimes corrupt assurances to patients based on unproven and, in some cases, dangerously dubious products," FDA Commissioner Scott Gottlieb said in a statement Monday.

The FDA has taken action against clinics in California and Florida.

The agency sent a warning letter to the US Stem Cell Clinic of Sunrise, Fla., and its chief scientific officer, Kristin Comella, for "marketing stem cell products without FDA approval and significant deviations from current good manufacturing practice requirements."

The clinic is one of many around the country that claim to use stem cells derived from a person's own fat to treat a variety of conditions, including Parkinson's disease, amyotrophic lateral sclerosis (ALS), and lung and heart diseases, the FDA says.

The Florida clinic had been previously linked to several cases of blindness caused by attempts to use fat stem cells to treat macular degeneration.

The FDA also said it has taken "decisive action" to "prevent the use of a potentially dangerous and unproven treatment" offered by StemImmune Inc. of San Diego, Calif., and administered to patients at California Stem Cell Treatment Centers in Rancho Mirage and Beverly Hills, Calif.

As part of that action, the U.S. Marshals Service seized five vials of live vaccinia virus vaccine that is supposed to be reserved for people at high risk for smallpox but was being used as part of a stem-cell treatment for cancer, according to the FDA. "The unproven and potentially dangerous treatment was being injected intravenously and directly into patients' tumors," according to an FDA statement.

Smallpox essentially has been eradicated from the planet, but samples are kept in reserve in the U.S. and Russia, and vaccines are kept on hand as a result.

But Elliot Lander, medical director of the California Stem Cell Treatment Centers, denounced the FDA's actions in an interview with Shots.

"I think it's egregious," Lander says. "I think they made a mistake. I'm really baffled by this."

While his clinics do charge some patients for treatments that use stem cells derived from fat, Lander says, none of the cancer patients were charged and the treatments were administered as part of a carefully designed research study.

"Nobody was charged a single penny," Lander says. "We're just trying to move the field forward."

In a written statement, U.S. Stem Cell also defended its activities.

"The safety and health of our patients are our number one priority and the strict standards that we have in place follow the laws of the Food and Drug Administration," according to the statement.

"We have helped thousands of patients harness their own healing potential," the statement says. "It would be a mistake to limit these therapies from patients who need them when we are adhering to top industry standards."

But stem-cell researchers praised the FDA's actions.

"This is spectacular," says George Daley, dean of the Harvard Medical School and a leading stem-cell researcher. "This is the right thing to do."

Daley praised the FDA's promise to provide clear guidance soon for vetting legitimate stem-cell therapies while cracking down on "snake-oil salesmen" marketing unproven treatments.

Stem-cell research is "a major revolution in medicine. It's bound to ultimately deliver cures," Daley says. "But it's so early in the field," he adds. "Unfortunately, there are unscrupulous practitioners and clinics that are marketing therapies to patients, often at great expense, that haven't been proven to work and may be unsafe."

Others agreed.

"I see this is a major, positive step by the FDA," says Paul Knoepfler, a professor of cell biology at the University of of California, Davis, who has documented the proliferation of stem-cell clinics.

"I'm hoping that this signals a historic shift by the FDA to tackle the big problem of stem-cell clinics selling unapproved and sometimes dangerous stem cell "treatments" that may not be real treatments," Knoepfler says.

Read more here:
FDA cracks down on stem-cell clinics selling unapproved treatments - 89.3 KPCC